Lenvatinib Plus Letrozole in Postmenopausal Women With HR+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer
Clin. Cancer Res 2022 Jun 01;28(11)2248-2256, JSJ Lim, ALA Wong, SGW Ow, NYL Ngoi, GHJ Chan, YLE Ang, WQ Chong, SE Lim, YW Lim, M Lee, JRE Choo, HL Tan, WP Yong, RA Soo, DSP Tan, CE Chee, R Sundar, K Yadav, S Jain, L Wang, BC Tai, BC Goh, SC LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.